Local bacillus Calmette-Guérin therapy for bovine vulval papilloma and carcinoma

F. W.G. Hill, V. P.M.G. Rutten*, M. H. Hoyer, W. R. Klein, J. W. Koten, P. A. Steerenberg, E. J. Ruitenberg, W. Den Otter

*Corresponding author for this work

    Research output: Contribution to journalArticleAcademicpeer-review

    Abstract

    Thirty cows from a pedigree Friesian dairy herd with bovine vulva papilloma and carcinoma were treated by intralesional injections of live bacillus Calmette-Guérin (BCG). This treatment induced total regression of all of six carcinomas. Whilst, after treatment, limited regression was also observed in advanced papillomas, BCG has little or no effect on the early stages of papillomas. This is the first study of BCG therapy in this type of cancer.

    Original languageEnglish
    Pages (from-to)49-52
    Number of pages4
    JournalCancer Immunology Immunotherapy
    Volume39
    Issue number1
    DOIs
    Publication statusPublished - 1 Jan 1994

    Keywords

    • BCG
    • Bovine vulval papilloma-carcinoma
    • Immunotherapy

    Fingerprint

    Dive into the research topics of 'Local bacillus Calmette-Guérin therapy for bovine vulval papilloma and carcinoma'. Together they form a unique fingerprint.

    Cite this